Japan's Fujifilm Holdings Corp said on Monday it was expanding the production of its Avigan anti-influenza drug to reach an additional number of Ebola patients.
Research
Bank of Japan Governor Haruhiko Kuroda's speech in Tokyo Ensures Achievement of the Price Stability Target of 2 percent through QQE
Bank of Japan Governor Haruhiko Kuroda delivered a speech at the Kisaragi-kai Meeting in Tokyo on 5th November 2014. He mainly spoke about ensuring achievement of the price stability target of 2 percent.
European Commission cuts Eurozone growth forecasts in 2014; European Union GDP forecast lowered the expectation for next two years
In its autumn forecasts European commission has revised down the growth forecasts for European Union and euro area. The report said, “Annual GDP growth in the EU this year is now projected to be 1.3%, while growth in the euro area is expected to be 0.8%.”
Boeing exec says NASA crash underscores need for new U.S. engine
The crash of an unmanned Orbital Sciences Antares rocket is a "wake-up call" to the U.S. space community about the need to develop a new U.S. rocket engine, the head of Boeing Co's defense division said on Thursday.
Google's Page, Virgin's Branson backed satellite on failed launch
Billionaire investors in a small, Seattle-area company that aims to one day mine resources on asteroids have not been deterred by an unmanned rocket explosion that destroyed their test satellite, the company said on Wednesday.
Latest News
Lockheed Martin Corp said on Wednesday it had made a technological breakthrough in developing a power source based on nuclear fusion, and the first reactors, small enough to fit on the back of a truck, could be ready for use in a decade.
AstraZeneca's cancer drug pipeline, already on a roll following promising clinical trial results, could get a further boost next week from a European green light for an experimental medicine against ovarian cancer.
A Chinese drugmaker with close military ties is seeking fast-track approval for a drug that it says can cure Ebola, as China joins the race to help treat a deadly outbreak of a disease that has spread from Africa to the United States and Europe.
Vernalis plc today announces that it has licensed worldwide rights in vipadenant (V2006), a small molecule A2A receptor antagonist, to RedoxTherapies Inc (Redox). Vipadenant has the potential to disrupt an immunosuppressive mechanism of tumor protection, generating improved efficacy for immunotherapies of certain cancers when used in combination.
California-based Mapp Biopharmaceutical Inc is making progress in efforts to boost production of the experimental Ebola treatment ZMapp, as the deadly virus continues to spread through West Africa and beyond, the company said Friday.
Russia plans to test launch its new heavy-lift Angara space rocket on Dec. 25, Interfax news agency quoted a source in the space industry as saying on Friday.
Wearable brain scanners and lasers that can turn hundreds of cells on and off were among 58 projects awarded $46 million in federal grants as part of President Obama's $100 million initiative to unlock the secrets of the human brain.
Watch out Harry Potter, you are not the only wizard with an invisibility cloak. Scientists at the University of Rochester have discovered a way to hide large objects from sight using inexpensive and readily available lenses a technology that seems to have sprung from the pages of J.K. Rowling's Harry Potter fantasy series.
As India celebrated becoming the first Asian nation to reach Mars, S.M. Vaidya, head of business at conglomerate Godrej's aerospace division that made the spacecraft's engine and thruster components, sounded surprisingly downbeat.
